Skip to main content
Markets
/
APLLTD · NSE
Market openNSE | BSE
Loading live market indices
AP
NSE · Equity shares · Biotechnology & Drugs

Alembic Pharmaceuticals APLLTD

NSE:INR 835Recorded price
BSE:INR 835.95Recorded price
Not available · Not available
Advanced chart
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceStale · last-known data
Company fundamentalsStale · last-known data
Research sections8 of 9 availableMissing source values remain unavailable, never zero-filled.
Snapshot

Price and key statistics

Reported and computed values remain separate; missing values are not converted to zero.

Previous closeData unavailable
Day rangeINR 816.55 — INR 836.7
52-week rangeINR 635.3 — INR 1,004.95
VolumeNot available
Market cap16,431.7
P/E23.33
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)7,344.9
Net Income (INR Cr)674.77
Rev Growth (5 Year %)6.37
EPS Growth (5 Year %)-10.32
P/E Ratio23.33
EPS37.73

Research path: Interpret Alembic Pharmaceuticals's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.

AI and Advanced

AI analysis and Advanced tools for APLLTD

Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.

AI analysisReview the complete evidence-led AI research workflow.Generate reportCreate a versioned report with entitlement and credit checks.Open AI ChatContinue a grounded conversation with the instrument in context.Advanced modulesOpen role- and entitlement-controlled portfolio and trading tools.
Validated OHLC

Interactive price chart

Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.

Open full workspace
Interactive price chartInteractive chart loads when this section is visible.
Auditable calculations

Daily technical summary

Calculated from validated daily candles. Descriptive research only.

Calculating technicals…
Intelligence: activity, structure and reported deals

Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.

Company derivatives · NSE

APLLTD futures & options

Expiry structure, futures, option chains and contract research.

Snapshot · timestamp unavailable
No observations

No matching contracts have verified observations for this filter.

DIRECTION · ACTIVITY · DISCLOSURES

APLLTD Intelligence

Stored price, volume, causal structure and reported deals for this stock.

Market map
Checking research access…

Volume and pressure are activity estimates, not net money inflow. Futures and options retain their separate observations above.

Company reporting

Financial statements

IND AS · INR crore

Metric202620252024
Total Liabilities Shareholders' Equity8,762.597,772.946,445.58
Accumulated Depreciation Total-1,809.51-1,593.79-1,328.5
Other Liabilities Total333.1124.31109.5
Accrued Expenses92.7384.0389.18
Long Term Debt121.92Not availableNot available
Common Stock Total39.3139.3139.31
Other Equity Total38.8611.8315.76
Other Current Assets Total50.2218.1320.41
Prepaid Expenses80.7669.1850.05
Total Assets8,762.597,772.946,445.58
Current Portof LT Debt/Capital Leases44.6515.1619.83
Additional Paid-In Capital748.39748.39748.39
Cash196.3783.48120.21
Total Equity5,674.815,190.944,818.2
Long Term Investments140.88127.2193.02
Retained Earnings(Accumulated Deficit)4,854.324,394.464,027.26
Total Common Shares Outstanding19.6619.6619.66
Property/Plant/Equipment Total-Gross5,286.094,954.564,399.56
Tangible Book Valueper Share Common Eq274.11264.09245.12
Total Liabilities3,087.782,5821,627.38
Total Debt1,429.941,257.5513.16
Cashand Short Term Investments196.3783.48120.21
Total Receivables Net1,677.751,585.681,186.06
Notes Payable/Short Term Debt1,218.611,195.57430.45
Accounts Receivable-Trade Net1,466.31,399.791,024.84
Property/Plant/Equipment Total-Net3,477.293,360.763,071.07
Minority Interest-5.83-1.42Not available
Total Current Liabilities2,593.832,412.341,455
Total Inventory2,567.492,331.321,701.83
Accounts Payable835.08879.89735.64
Other Currentliabilities Total402.76237.69179.9
Total Long Term Debt166.6846.7762.88
Intangibles Net286.7800
Other Long Term Assets Total269.62166.03169.63
Note Receivable-Long Term15.4331.1533.3
Unrealized Gain(Loss)-6.07-3.05-12.52
Total Current Assets4,572.594,087.793,078.56
Capital Lease Obligations44.7646.7762.88
Fundamentals

Valuation and ratios

Valuation

PEG Ratio0.91

Price to Sale Ratio2.24

Growth

Debt 5Yr CAGR %19.63

Margins

Operating Margin 12m9.76

Operating Margin 5y Avg10.14

Net Profit Margin 12m8.86

Net Profit Margin 5y8.74

Yield

Dividend Yield %1.47

Risk and consensus

Source-qualified signals

Risk metrics

Overall RiskBalanced risk

Board Risk31.8

Analyst consensus

ConsensusBuy

Consensus score2.22

Analyst opinions9

Strong Sell count0

Sell count0

Hold count5

Buy count1

Strong Buy count3

Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.
Industry context

Peer comparison

Only peers present in the company profile payload are displayed.

CompanyPriceMarket capP/EResearch
Sun Pharmaceutical IndustriesINR 1,9444.66 L38.4—
Divi's LaboratoriesINR 8,291.552.20 L73.32—
Torrent PharmaceuticalsINR 4,9651.89 L72.73—
CiplaINR 1,4751.19 L27.57—
Zydus LifesciencesINR 1,106.251.10 L21.19—
Shareholding

Ownership

Promoter
69.87%
FII
4.17%
MF
8.73%
Other
17.23%
Corporate actions

Events

  1. annual General MeetingAGM
  2. board MeetingsQuarterly Results
  3. dividendRs.12.0000 per share(600%)Final Dividend
  4. board MeetingsAudited Results & Final Dividend
  5. annual General MeetingPOM
  6. board MeetingsQuarterly Results
  7. board MeetingsTo consider other business matters.
  8. board MeetingsTo consider other business matters.
  9. dividendRs.11.0000 per share(550%)Final Dividend
  10. board MeetingsAudited Results & Final Dividend
  11. annual General MeetingPOM
  12. board MeetingsTo consider other business matters.
  13. board MeetingsQuarterly Results
  14. board MeetingsQuarterly Results
  15. annual General MeetingAGM
  16. dividendRs.11.0000 per share(550%)Final Dividend
  17. board MeetingsAudited Results & Final Dividend
  18. board MeetingsQuarterly Results
  19. board MeetingsQuarterly Results
  20. board MeetingsQuarterly Results
Rusaka Markets Community

Discussion and sentiment for Alembic Pharmaceuticals

Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.

Rusaka Markets Community

Community discussion loads as you approach this section.

Company profile

Business information

What the company does

Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing and marketing Indian Formulations, International Generics, and Active Pharmaceutical Ingredients (APIs) across the globe. It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopedic and Gynecology. Its products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It also has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its Indian Formulations.

Company facts

Industry
Biotechnology & Drugs
Sector
Biotechnology & Drugs
NSE Code
APLLTD
BSE Code
533573
Questions

Stock FAQ

What is the symbol and ISIN of Alembic Pharmaceuticals?

Alembic Pharmaceuticals has the symbol APLLTD and ISIN - INE901L01018.

What is the latest recorded price of Alembic Pharmaceuticals?

The latest available recorded price of Alembic Pharmaceuticals is INR 835.00 as of 2026-08-06T20:55:28.171Z. This is a source-stamped snapshot, not a live quote.

What are the year high and year low of Alembic Pharmaceuticals?

Year high: INR 1,004.95. Year low: INR 635.30.

What is the market capitalization of Alembic Pharmaceuticals?

Market capitalization: INR 16,431.70 crore.

What is the P/E ratio of Alembic Pharmaceuticals?

P/E ratio: 23.33.

What is the dividend yield of Alembic Pharmaceuticals?

Dividend yield: 1.47%.

How is the financial performance of Alembic Pharmaceuticals based on revenue, net income, and EPS?

Revenue: INR 7,344.90 crore. Net income: INR 674.77 crore. EPS: INR 37.84.

What are the price-to-book and price-to-sales ratios of Alembic Pharmaceuticals?

Price-to-book ratio is unavailable in the current source. Price-to-sales ratio: 2.24.

Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.